AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Influence of the Timing of Postoperative Rehabilitation Intervention on the Clinical Efficacy of Unilateral Biportal Endoscopic Spine System in the Treatment of Lumbar Disc Herniation

RecruitingNAAges 19 Years - 65 YearsAllLi Xiang
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study focuses on the impact of the timing of postoperative rehabilitation intervention on the clinical efficacy of unilateral biportal endoscopic spine surgery in the treatment of lumbar disc herniation. The main objective is to explore this impact and provide high-quality evidence-based medical evidence for making reasonable clinical decisions.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Aged between 19 and 65 years. Diagnosed with lumbar disc herniation by imaging and scheduled for unilateral biportal endoscopic (UBE) surgery. Presenting with radicular pain in the lower extremity, with a history of less than 1 year. Able to understand Chinese and complete questionnaires independently. Physically capable of participating in exercise rehabilitation. Willing to participate and provide written informed consent. Exclusion Criteria: * Aged under 18 or over 65 years. Combined with other spinal pathologies (e.g., ankylosing spondylitis, rheumatoid arthritis, spinal tumor, spinal fracture, cauda equina syndrome). Diagnosis of neurological disorders (e.g., multiple sclerosis, Parkinson's disease). Presence of uncontrolled cardiovascular, respiratory, or peripheral vascular diseases. History of severe psychiatric disorders (e.g., schizophrenia). Previous history of spinal surgery. Pregnancy or lactation. Inability to understand or comply with the study procedures.
๐Ÿ’Š

What it tests

  • Standardized Postoperative Rehabilitation Protocol
๐Ÿ“

Where

1 site
Beijing Friendship Hospital
Beijing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy